Russell Investments Group
GPCR icon

Russell Investments Group’s Structure Therapeutics GPCR Stock Holding History

Russell Investments Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,701
Closed -$516K – 4440
2026
Q1 		$516K Sell
10,701
-15,573
-59% -$1.07M ﹤0.01% 2488
2025
Q4 		$1.83M Buy
+26,274
New +$1.07M ﹤0.01% 1922
2025
Q1 		– Sell
-34,671
Closed -$940K – 3828
2024
Q4 		$940K Buy
34,671
+2,888
+9% +$102K ﹤0.01% 2037
2024
Q3 		$1.39M Buy
31,783
+13,196
+71% +$510K ﹤0.01% 1876
2024
Q2 		$730K Sell
18,587
-3,125
-14% -$128K ﹤0.01% 2083
2024
Q1 		$931K Sell
21,712
-6,681
-24% -$282K ﹤0.01% 1999
2023
Q4 		$1.16M Buy
+28,393
New +$1.63M ﹤0.01% 1895

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Russell Investments Group's GPCR Position: Q2 2026 in Review

Russell Investments Group sold out of Structure Therapeutics (GPCR) in Q2 2026, closing a stake of 10,701 shares — an estimated $516K sold.

Russell Investments Group first reported a position in GPCR in Q4 2023 and held it in 7 quarters. The position peaked at $1.83M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Russell Investments Group reported no remaining Structure Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 10,701 Structure Therapeutics shares in Q2 2026, an estimated $516K.
  • Russell Investments Group first reported a position in Structure Therapeutics in Q4 2023 and held it in 7 quarters.
  • Russell Investments Group's Structure Therapeutics position peaked at $1.83M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.